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Abstract 
Pheochromocytomas and sympathetic paragangliomas are rare catecholamine-secreting tumours that represent very rare causes of in-
tracerebral haemorrhage in the young, with only a few cases reported.
A 32-year-old man presented to our emergency department because of sudden onset of severe headache. He had a six-month history of 
paroxysmal headache, palpitations, and sweating. During examination he became somnolent and developed left-sided hemiplegia. A com-
puted tomographic (CT) scan of the brain showed a right temporoparietal haematoma. He was admitted to the Clinic for Neurosurgery 
and the haematoma was evacuated. The patient was comatose, on assisted respiration, with frequent hypertensive crises. An examination 
for possible secondary causes of hypertension was undertaken. Plasma metanephrine value was elevated (414 pg/mL, reference values 
< 90 pg/mL). Abdominal CT scans revealed a large mass (6 cm) in the right adrenal gland. After adequate control of the hypertension was 
achieved with nonselective a- and b-adrenergic blockers the tumour was excised. The histopathologic findings confirmed the diagnosis 
of pheochromocytoma. The genetic analysis demonstrated a duplication in exon 1 of the VHL gene.
We reported a rare, potentially fatal complication of pheochromocytoma — an intracerebral haemorrhage. This case and review of similar 
rare cases in the literature illustrate the importance of early recognition of the characteristic symptoms of catecholamine excess in young 
patients with hypertension. (Endokrynol Pol 2019; 70 (3): 298–303)
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Introduction 
Intracerebral haemorrhage in the young is usually 
caused by arteriovenous malformations, cavernous 
angiomas, or hypertension, followed by cerebral venous 
thrombosis, eclampsia, and sympathomimetic drugs 
[1, 2]. Pheochromocytomas and sympathetic paragan-
gliomas are rare catecholamine-secreting tumours and 
represent very rare causes of intracerebral haemorrhage 
in the young. These tumours usually manifest with 
paroxysms of hypertension, headache, palpitations, 
sweating, and pallor. Most cases are sporadic, but they 
may be part of hereditary syndromes in 40–70% of 
cases [3, 4].
Pheochromocytoma crisis is an endocrine emer-
gency associated with significant mortality. It has 
been defined as the acute severe presentation of 
catecholamine-induced haemodynamic instability 
causing end-organ damage or dysfunction [5, 6]. In rare 
patients, pheochromocytoma crisis may be the first clini-
cal manifestation of the underlying tumour. The most 
common presentation of pheochromocytoma crisis is 
hypertensive crisis or catecholamine cardiomyopathy 
[6]. The recommended management of pheochromocy-
toma crisis includes the use of a-blockade, and surgical 
intervention should be deferred until medical stabilisa-
tion has been achieved [6].
Some cases of these catecholamine-secreting tu-
mours presenting with intracerebral haemorrhage have 
been reported, two of them as autopsy cases [2, 7–15] 
(Tab. I). All these patients were young adults (except two 
children) and one patient had haemorrhagic stroke as 
the presenting feature of pheochromocytoma during 
pregnancy [7, 11, 14].
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a1/a2 antagonist was initiated (phenoxybenzamine 
with a starting dose of 10 mg orally three times a day, 
increasing to 160 mg/d) and later b-blocker therapy 
was added (propranolol 80 mg/d). The patient was 
haemodynamically instable, with frequent hyperten-
sive crises, and it took four months for adequate blood 
pressure control. During the preoperative period he de-
veloped severe complications (sepsis and deep venous 
thrombosis). After a waiting period of four months, 
during which the patient’s condition stabilised, a right 
adrenalectomy was performed, with removal of the 
tumour of the right adrenal gland. Macroscopically, the 
tumour was dark brown, soft, with solid appearance 
on cross section. Tumour mass was 82 gr, with maxi-
mal diameter of 70 mm. The pathologic examination 
revealed a pheochromocytoma with a PASS score of 5 
We report a young male with adrenal pheochromo-
cytoma presenting with intracerebral haemorrhage, and 
we perform a review of similar cases in the literature.
Case report
A 32-year-old male presented to the Emergency De-
partment because of sudden onset of severe headache. 
He had had paroxysmal attacks of severe headaches, 
palpitations, sweating, nervousness, tremor, and ab-
dominal pain over a six-month period. Blood pressure 
was never measured during these attacks. Four months 
before the presentation in the Emergency Department 
he had blurred vision and was examined by an oph-
thalmologist. Diagnosis of retrobulbar neuritis was 
made and the patient was treated with corticosteroids 
(prednisone 40 mg/day). During the examination in 
the Emergency Department, the patient became som-
nolent with a left-sided hemiplegia. Brain computed 
tomography (CT) scan revealed right temporoparietal 
haemorrhage (Fig. 1). A cerebral angiogram did not 
demonstrate a vascular anomaly. The patient was 
operated, and the intracerebral haematoma was evacu-
ated. The postoperative period was complicated with 
hypertensive crisis. During crisis, the blood pressure 
was 240/160 mmHg, with a heart rate of 150 beats per 
minute, and the patient had hyperthermia (40°C) with 
sweating and tremor. The sudden onset of severe hyper-
tension raised the suspicion of secondary hypertension, 
especially pheochromocytoma. Abdominal CT scan 
revealed a rounded mass of 6 cm in the right adrenal 
gland (Fig. 2). Plasma metanephrine value was elevated 
(414 pg/mL, reference values < 90 pg/mL). Routine 
laboratory test findings were within normal limits, 
urinalysis results were negative, and chest radiography 
was normal. Serum calcium level, parathormone, and 
calcitonin were within reference ranges. The diagnosis 
of pheochromocytoma was made, and non-competitive 
Figure 1. Brain CT scan showing intracranial haemorrhage 
located in the right temporoparietal region
Figure 2AB. Abdominal CT scan showing a well-defined heterogenous mass in the region of the right adrenal gland
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(eight mitoses on 10 high-magnification fields, atypical 
mitotic figures, with vascular invasion) (Fig. 3). Micro-
scopically, the tumour was clearly encapsulated, with 
alveolar architecture, formed from medium-sized cells 
with amphophilic cytoplasm and with moderately poly-
morphic nuclei. Increased number and atypical mitoses 
were noticeable, as well as vascular invasion with the 
tumour (Fig. 3C and 3D). Immunohistochemically, the 
tumour cells were positive for chromogranin A and 
negative for melan A (Fig. 3A and 3B). Evidence for 
vascular invasion was obtained with CD31 staining for 
endothelial cells that line the vascular spaces (Fig. 3C).
Despite a negative family history, the occurrence of 
pheochromocytoma in a young patient strongly sug-
gested the need for genetic analysis. Genetic testing 
was negative for germline mutations in SDHB, SDHD, 
and VHL genes. Multiplex ligation-dependent probe 
amplification (MLPA) showed duplication of exon 1 of 
the VHL gene. During the postoperative period and 
after the discontinuation of antihypertensive therapy, 
the patient was normotensive. Two months after right 
adrenalectomy, his condition improved, he was con-
scious, and with spontaneous respiration. Verbal com-
munication was established, and the patient was sent 
for physical rehabilitation. The patient was followed for 
two years after adrenalectomy. He was normotensive 
without antihypertensive therapy. Repeated blood 
analysis showed normal chromogranin A (87 ng/mL, 
reference values < 125 ng/mL). Urinary catecholamine 
levels were normal (adrenaline 2.3 μg/d, reference 
values < 20 μg/d; noradrenaline 9.3 μg/d, reference 
values < 105 μg/d; dopamine 60 μg/d, reference val-
ues < 450 μg/d). Ophthalmoscopy was normal, control 
abdominal CT scan was normal, and brain CT scan did 
not show intracranial lesions.
Discussion
Pheochromocytomas and sympathetic paraganglio-
mas are rare neuroendocrine tumours that produce 
an excess of catecholamines, causing hypertension, 
headache, palpitations, sweating, tremor, and pallor. 
The annual prevalence is estimated to be about one 
or two per million persons [16]. These tumours may 
present in many ways, and they are known as the 
“disease with a thousand faces” [17]. Patients with 
pheochromocytomas/paragangliomas will often pres-
ent with a history of poorly controlled or accelerated 
hypertension with symptoms (palpitations, head-
aches, inappropriate sweating, pallor, panic or anxiety 
attacks, abdominal pain, dyspnoea, weight loss) [17, 
18]. Also, cyclic rapid fluctuation of hypertension and 
Figure 3. A. Diffuse granular cytoplasmic staining for chromogranin A (200×); B. Tumour cells were negative for melan A (200×); 
C. Vascular invasion (arrows); D. Atypical mitosis (arrow, Ki67 staining) (400×)
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hypotension, shock, ventricular dyskinesias, various 
electrocardiographic (ECG) abnormalities, and pulmo-
nary oedema may comprise the initial presentation of 
catecholamine excess [19–21]. Very rarely, pheochro-
mocytomas and paragangliomas may present with 
intracerebral haemorrhage, and some cases have 
been reported in adults and in the paediatric popula-
tion [2, 7–15]. We reviewed these cases, with our case 
presented in Table I. The sex distribution of published 
cases was equal, and the mean age at presentation of 
intracerebral haemorrhage was 25.4 ± 4.0 years (range, 
6–51 years). The mean duration of symptoms before 
the diagnosis of pheochromocytoma was 2.5 ± 0.7 
years (range, 0–7 years), and in our patient it was six 
months. One patient had haemorrhagic stroke as the 
presenting feature of pheochromocytoma during preg-
nancy, at the 35th gestational week [7]. Two patients 
died, and autopsy revealed pheochromocytomas [9, 
15]. In this series of patients, six patients had pheo-
chromocytomas (bilateral in two patients, bladder 
pheochromocytoma in one patient), three patients had 
paragangliomas (multiple in one patient, malignant in 
one patient), and one patient had both pheochromo-
cytoma and paragangliomas (Tab. I). Genetic analysis 
was performed in three patients: one with SDHD gene 
mutation, one with SDHB gene mutation (both with 
paragangliomas), and one patient was negative for 
screened gene mutations. According to clinical data, 
a female patient diagnosed during pregnancy had 
MEN2A syndrome, while there were no data for other 
patients in this series. Our patient had duplication of 
exon 1 of the VHL gene.
Table I. Intracerebral hemorrhage in patients with pheochromocytoma / paragangliomas
Authors 
& Year
Sex 
(M/F)
Age at 
presentation 
(years)
Duration of 
symptoms 
prior diagnosis 
(years)
Neurological 
signs and 
symptoms
Tumor localization
Preoperative 
antihypertensive 
regiment
Genetic 
analysis
Moraca-
Kvapilovaet et 
al., 1985
F 30
Diagnosed 
during 
pregnancy 
(35week)
Left hemiparesis, 
diaphoresis
Bilateral 
pheochromocytoma
Methyldopa + 
diuretics
MEN 2A 
Sy (clinical 
data)
Scardigli et 
al., 1985 F 24 7
Coma, 
quadriplegia Pheochromocytoma
Phenoxybenzamine 
+ metoprolol + 
metyrosine
NR
Aikawa et al., 
2000 M 35 0 Coma Pheochromocytoma Autopsy report NR
Moritani et al., 
2001 M 51 3 Right hemiplegia
Bladder 
pheochromocytoma
Doxasocin  
+ propranolol  
+ amlodipine
NR
Chuang et al., 
2002 M 6 0.5
Right 
hemiparesis, 
focal seizure
Pheochromocytoma a, b and calcium channel blockers NR
Park et al., 
2006 M 18 2
Headache, left 
hemianopia
Paraganglioma in left 
paraaortic area NR NR
Douma et al., 
2008 F 25 5
Dysarthria, right 
hemiparesis
Paraganglioma, 
pheochromocytoma
Phenoxybenzamine  
30 mg/d + atenolol  
25 mg/d
Negative for 
RET, VHL, 
NF1, SDHB, 
SDHD
Petramala et 
al., 2008 F 23 0.5 Left hemiplegia
Multiple 
paragangliomas
Doxazocin + 
propranolol + 
amlodipine
SDHD
Luiz et al., 
2013 M 12 4
Headache, 
diaphoresis, left 
hemiparesis
Malignant 
paraganglioma 
(Zuckerkandl)
NR SDHB
Mizukami et 
al., 2013 F 30 3 Death
Bilateral 
pheochromocytoma Autopsy report NR
Our patient M 32 0.5
Headache, 
palpitations, 
diaphoresis, left 
hemiplegia
Pheochromocytoma
Phenoxybenzamine  
160 mg/d + 
propranolol 80 mg/d  
(4 months)
VHL
NR — not reported
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The mechanisms that lead to a sudden increase in 
catecholamine release are varied and not fully under-
stood. There are some widely accepted precipitants, 
like insufficient/compromised tumour blood supply, 
direct or indirect physical stimulus to tumour, general 
anaesthesia, pregnancy, and some drugs [6]. Steroids 
are described in occasional case reports as a precipitant 
of pheochromocytoma crisis [22]. Our patient was 
treated with prednisone four months before intra-
cranial haemorrhage due to hypertensive crisis, and 
it is possible that prednisone precipitated a surge in 
catecholamine release.
Management of patients with pheochromocytoma 
crisis should include haemodynamic stabilisation 
before surgery. The only indication for emergency 
surgery without medical stabilisation for crisis patients 
is shock due to haemorrhagic necrosis or rupture of 
a pheochromocytoma, with progressive multiorgan 
failure. Crisis patients who have undergone emer-
gency surgery without medical stabilisation have more 
intraoperative and postoperative complications and 
have higher mortality, compared with patients who 
have undergone elective surgery [23]. Our patient 
had severe pheochromocytoma crisis, with frequent 
paroxysms of hypertension, which were difficult to 
treat. He required high doses of a-blockers in com-
bination with other medications for four months, 
before haemodynamic stabilisation was achieved, and 
adrenalectomy was performed without complications 
during the surgery.
It is currently accepted that up to 35% of pheochro-
mocytoma/paraganglioma are associated with inher-
ited gene mutations [24–29]. Almost one fourth of pa-
tients with apparently sporadic pheochromocytoma 
(non-syndromic pheochromocytoma without a family 
history of the disease) are carriers of mutations [24]. 
Younger age, multifocal tumours, and extra-adrenal 
tumours are significantly associated with the presence 
of a mutation. Our patient was young and presented 
dramatically with intracerebral haemorrhage. He was 
screened for germline mutations of genes associated 
with familial pheochromocytoma/paragangliomas, 
and MLPA analysis revealed a duplication of exon 1 
of the VHL gene. Our patient had only pheochromo-
cytoma without other classical lesions of VHL disease 
and was classified as VHL type 2C. His pathohistologi-
cal finding of vascular invasion and atypical mitosis 
raised the possibility of tumour recurrence. After two 
years of follow-up, the patient was still disease-free. 
It is necessary to maintain lifelong clinical follow-up 
of the patient by both laboratory and radiological 
investigation in addition to following the patient’s 
symptoms.
Conclusions
We report a young adult patient with pheochromocyto-
ma presenting with intracerebral haemorrhage caused 
by severe hypertension, possibly with prednisone as 
a precipitant of a sudden increase in catecholamine 
release. Physicians evaluating children and young 
adults with intracerebral haemorrhage, particularly 
if hypertension is present, should consider the pos-
sibility of catecholamine-secreting tumours. Close col-
laboration between endocrinologists, anaesthetists, and 
endocrine surgeons is needed in these difficult cases of 
pheochromocytoma crisis.
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